Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01BX002950-01 |
| Title: | Retinal Ganglion Cell Differentiation and Transplantation |
| Principal Investigator: | Jeffrey Goldberg |
| Location: | Palo Alto, CA |
| Congressional District Code: | 52 |
| Research Service: | Biomedical Laboratory R&D |
| Project Period: | January 2017 - December 2020 |
| FY 2021 Funding Amount: | $42,000 |
| Total Award Amount (all years): |
$745,500 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Optic nerve degenerations as seen in glaucoma, ischemic and traumatic optic neuropathies, are a leading cause of blindness in the U.S. and worldwide, and are very common in the veteran popuation. They are characterized by loss of retinal ganglion cells (RGCs), which are not replaced by endogenous mechanisms, and thus vision loss is generally irreversible. Cell transplantation therapies provide new hope to protect or even to replace degenerated RGCs and restore visual function. However, little is... |